Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: September 7, 2026 at 7:09 AM UTC
| NCT Number | NCT06768489 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE1 |
| Target Enrollment | 240 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Janssen Research & Development, LLC |
| Last Updated on CT.gov | July 31, 2026 (Jul 31, 2026) |
As of September 7, 2026: Clinical trial NCT06768489 is currently recruiting participants. This phase1 study for multiple myeloma is actively seeking new participants at 2 locations across the United States. The study is sponsored by Janssen Research & Development, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06768489 is actively recruiting participants as of September 7, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06768489 was last updated Jul 31, 2026 (July 31, 2026). HelloStudys verifies this status automatically.